Ireland· IE-PA-PPA1463/177/001
Campral EC 333 mg Gastro-resistant tablets
A acamprosate product containing acamprosate calcium, registered in Ireland by IMED Healthcare Ltd.,. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Acamprosate is registered in 14 of 19 countries.
Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Acamprosate · ATC N07BB03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acamprosate costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Acamprosate · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.37
- IT Italy$2.75
- FR France$1.14
The record
At a glance
HPRA (Ireland)- Active substance
- Acamprosate calcium
- Manufacturer
- IMED Healthcare Ltd.,
- Country
- Ireland (IE)
- ATC code
- N07BB03
- ATC class
- Acamprosate
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA1463/177/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for acamprosate.
Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acamprosate · interactions on record
19 records
Same medicine, other countries
Acamprosate in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAcamprosate 333mg gastro-resistant tabletsAlliance Healthcare (Distribution) Ltd
- United Statesacamprosate calciumZydus Lifesciences Limited
- SwedenAkamprosat Viatris 333 mg EnterotablettViatris Limited
- NetherlandsCampral 333 mg, maagsapresistente tablettenEuro Registratie Collectief B.V.
- FranceACAMPROSATE BIOGARAN 333 mg, comprimé pelliculé gastro-résistantBIOGARAN
- NorwayCampralMerck Santé s.a.s.
- BelgiumCampral 333 mgMerck
- PolandCampralMerck Sante s.a.s.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Campral
- Belgium · Campral
- Czechia · Campral
- Germany · Campral
- Spain · Campral
- France · Acamprosate Biogaran, Acamprosate Viatris
- United Kingdom (Northern Ireland) · Acamprosate Generics [uk] Ltd, Acamprosate Strandhaven Somex Pharma
- Italy · Campral
- Luxembourg · Campral
- Netherlands · Campral
- Norway · Campral
- Poland · Campral
- Portugal · Campral
- Sweden · Akamprosat Viatris, Campral
- Slovakia · Acamprosat Viatris, Campral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eba5bcbd-d03a-49ef-8cbc-7a26bba553a6 GET /v1/drugs/eba5bcbd-d03a-49ef-8cbc-7a26bba553a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gastro-resistant tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N07BB",
"N07BB03"
],
"strength": null,
"pa_number": "PPA1463/177/001",
"substances": [
"Acamprosate calcium"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "02/07/2021",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about acamprosate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.